Financial Disclosure by Clinical Investigators; Correction
other · Food and Drug Administration · Rule · Published 1998-06-29 · 63 FR 35134
Document
Document number
98-17145
Federal Register citation
63 FR 35134
CFR reference
21 CFR 54
Type
Rule
Action
Final rule; correction.
Category
other
Sub-agency
Food and Drug Administration
Publication date
1998-06-29
HHS docket
Docket No. 93N-0445
Abstract
The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of February 2, 1998 (63 FR 5233). The document issued regulations requiring the sponsor of any drug, including a biological product, or device marketing application (applicant), to submit certain information covering the compensation to, and financial interests of, any clinical investigator conducting certain clinical studies. The document was published with an error. This document corrects that error.